WO2010036135A3 - Textile utilisé en particulier dans la production de pansements - Google Patents

Textile utilisé en particulier dans la production de pansements Download PDF

Info

Publication number
WO2010036135A3
WO2010036135A3 PCT/PL2009/050028 PL2009050028W WO2010036135A3 WO 2010036135 A3 WO2010036135 A3 WO 2010036135A3 PL 2009050028 W PL2009050028 W PL 2009050028W WO 2010036135 A3 WO2010036135 A3 WO 2010036135A3
Authority
WO
WIPO (PCT)
Prior art keywords
textile
production
wound dressings
possessing
genetically modified
Prior art date
Application number
PCT/PL2009/050028
Other languages
English (en)
Other versions
WO2010036135A2 (fr
Inventor
Jan SZOPA-SKÓRKOWSKI
Magdalena ŻUK
Katarzyna SKÓRKOWSKA-TELICHOWSKA
Original Assignee
Borkowski, Marek
MAJORKOWSKI, Jarosław
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Borkowski, Marek, MAJORKOWSKI, Jarosław filed Critical Borkowski, Marek
Publication of WO2010036135A2 publication Critical patent/WO2010036135A2/fr
Publication of WO2010036135A3 publication Critical patent/WO2010036135A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/34—Oils, fats, waxes or natural resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine

Abstract

L'invention concerne un textile utilisé en particulier dans la production de pansements. Ce textile contient une fibre de lin génétiquement modifiée produite à partir de lin contenant des cellules génétiquement modifiées présentant une construction à trois gènes comprenant un ADNc codant des enzymes de synthèse des flavonoïdes, à savoir la chalcone synthase (CHS), la chalcone isomérase (CHI) et la dihydroflavonol réductase (DFR), ou une construction à gène unique comprenant un ADNc codant la glucose transférase. Le textile selon l'invention est utilisé de préférence dans la production de pansements utilisés pour traiter des lésions corporelles d'origine mécanique, physique ou chimique.
PCT/PL2009/050028 2008-09-29 2009-09-29 Textile utilisé en particulier dans la production de pansements WO2010036135A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PLPL386185 2008-09-29
PL386185A PL213595B1 (pl) 2008-09-29 2008-09-29 Tkanina, zwlaszcza do wytwarzania opatrunków

Publications (2)

Publication Number Publication Date
WO2010036135A2 WO2010036135A2 (fr) 2010-04-01
WO2010036135A3 true WO2010036135A3 (fr) 2010-12-16

Family

ID=41600335

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2009/050028 WO2010036135A2 (fr) 2008-09-29 2009-09-29 Textile utilisé en particulier dans la production de pansements

Country Status (2)

Country Link
PL (1) PL213595B1 (fr)
WO (1) WO2010036135A2 (fr)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1477571A (en) * 1973-10-05 1977-06-22 Personal Products Co Absorbent dressing
WO2000038607A1 (fr) * 1998-12-24 2000-07-06 Bki Holding Corporation Structures absorbantes de fibres de cellulose traitees chimiquement
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
EP1609462A1 (fr) * 2004-04-22 2005-12-28 JUVENA (International) AG Préparation cosmétique ou dermatologique comprenant un milieu nutritif
US20070141934A1 (en) * 2005-12-15 2007-06-21 Kimberly-Clark Worldwide, Inc. Nonwoven webs containing bacteriostatic compositions and methods of making the same
US20070160653A1 (en) * 2006-01-11 2007-07-12 Fischer Thomas H Hemostatic textile
WO2008079898A1 (fr) * 2006-12-20 2008-07-03 Pharmwest, Inc. Méthodes et formulations topiques comprenant un métal colloïdal servant à traiter ou prévenir des affections cutanées

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1477571A (en) * 1973-10-05 1977-06-22 Personal Products Co Absorbent dressing
WO2000038607A1 (fr) * 1998-12-24 2000-07-06 Bki Holding Corporation Structures absorbantes de fibres de cellulose traitees chimiquement
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
EP1609462A1 (fr) * 2004-04-22 2005-12-28 JUVENA (International) AG Préparation cosmétique ou dermatologique comprenant un milieu nutritif
US20070141934A1 (en) * 2005-12-15 2007-06-21 Kimberly-Clark Worldwide, Inc. Nonwoven webs containing bacteriostatic compositions and methods of making the same
US20070160653A1 (en) * 2006-01-11 2007-07-12 Fischer Thomas H Hemostatic textile
WO2008079898A1 (fr) * 2006-12-20 2008-07-03 Pharmwest, Inc. Méthodes et formulations topiques comprenant un métal colloïdal servant à traiter ou prévenir des affections cutanées

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LORENC-KUKULA ET AL: "Engineering flax with increased flavonoid content and thus Fusarium resistance", PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY, ACADEMIC PRESS LTD, GB LNKD- DOI:10.1016/J.PMPP.2007.05.005, vol. 70, no. 1-3, 18 September 2007 (2007-09-18), pages 38 - 48, XP022258363, ISSN: 0885-5765 *
LORENC-KUKULA KATARZYNA ET AL: "Pleiotropic effect of phenolic compounds content increases in transgenic flax plant", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 53, no. 9, May 2005 (2005-05-01), pages 3685 - 3692, XP002605060, ISSN: 0021-8561 *

Also Published As

Publication number Publication date
WO2010036135A2 (fr) 2010-04-01
PL386185A1 (pl) 2010-04-12
PL213595B1 (pl) 2013-03-29

Similar Documents

Publication Publication Date Title
WO2013036918A3 (fr) Production de poly(α-1,3-glucane) hautement linéaire de titre élevé
WO2011061032A3 (fr) Cellules, acides nucléiques, enzymes et leur utilisation, ainsi que procédé de production de sophorolipides
EP2481479A4 (fr) Catalyseur pour l'hydrolyse de la cellulose ou de l'hémicellulose, et procédé de production d'une solution contenant un sucre à l'aide dudit catalyseur
WO2010138941A3 (fr) Cellulose modifiée à base de fibres kraft chimiques et procédés de fabrication et d'utilisation de celle-ci
EP3957321A3 (fr) Polysaccharides capsulaires de streptococcus pneumoniae et conjugués de ceux-ci
WO2008040969A3 (fr) Procédé
WO2012027282A3 (fr) Enzymes recombinantes capables de dégrader la lignocellulose utilisables en vue de la production de sucres solubles à partir de biomasse cellulosique
WO2010104391A3 (fr) Préparation d'acide adipique
MY160680A (en) Process for producing molecules containing specialized glycan structures
WO2008132743A3 (fr) Production de protéines à teneur élevée en mannose dans la culture de plantes
TN2011000628A1 (en) Production of polio virus at high titres for vaccine production
IN2012DN00403A (fr)
WO2011060048A3 (fr) Procédés de fabrication d'un copolymère de polyhydroxyalcanoate avec une teneur élevée en monomère à longueur de chaîne moyenne
JP2012503478A5 (fr)
WO2011022548A3 (fr) Polypeptides de kétoréductase pour la préparation de phényléphrine
WO2010124312A3 (fr) Procédé de préparation de produits de dégradation des glucides à partir d'une matière lignocellulosique
MY159293A (en) Process for manufacturing branched aromatic polycarbonate resin with desired degree of branching
WO2010041247A3 (fr) Silice hautement dispersible pour caoutchoucs et son processus d’obtention
WO2010104794A3 (fr) Procédé perfectionné pour la génération de méthane
WO2011080078A3 (fr) Xylanase thermostable pour hydrolyse sélective de polysaccharides contenant du pentose
MX343699B (es) Construcción de expresión de adn.
WO2010140862A3 (fr) CASSETTE D'EXPRESSION DE shARN MULTI-CISTRONIQUE POUR SUPPRIMER UN OU PLUSIEURS GÈNES CIBLES
WO2010036135A3 (fr) Textile utilisé en particulier dans la production de pansements
EP2436677A4 (fr) Triallylisocyanurate, triallylcyanurate et procédé de fabrication de triallylisocyanurate
WO2010009021A3 (fr) Processus de fabrication d’oxyde d’éthylène au moyen de la technologie de processus en microcanal

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09756862

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09756862

Country of ref document: EP

Kind code of ref document: A2